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Early duplex scanning after infrainguinal
endovascular therapy
Misty D. Humphries, MD, William C. Pevec, MD, John R. Laird, MD, Khung Keong Yeo, MD,
Nasim Hedayati, MD, and David L. Dawson, MD, Sacramento, Calif
Objectives: Duplex ultrasound scanning (DUS) has benefit for intraoperative and subsequent evaluation of surgical
bypasses in the lower extremities. The utility of DUS after endovascular revascularizations is not established. This study
was performed to evaluate whether DUS findings after infrainguinal endovascular interventions for critical limb ischemia
(CLI) were predictive of need for reintervention or amputation.
Methods: To identify the study cohort, peripheral interventions for CLI (Rutherford grades 4, 5, 6) over a 24-month
period (2006-2007) were reviewed. DUS findings were considered indicative of hemodynamic stenosis if the peak systolic
velocity (PSV) was>180 cm/s or the PSV velocity ratio was>2.0. Demographic, clinical, procedural, and outcomes were
examined. SVS and TASC II classifications and reporting standards were used. Arteriograms were reviewed and treated
segments were categorized as patent (<30% residual stenosis) or abnormal (>30% residual stenosis).
Results: There were 122 infrainguinal interventions for CLI in 113 patients (53% male; mean age 71 years). Risk factors
included diabetes: 61%; renal failure: 20%; and smoking (within 1 year): 40%. DUS was performed within 30 days of the
index procedure in 90 cases. Fifty patients had an abnormal early duplex and 40 patients had a normal duplex. In patients
with a normal duplex ultrasound the amputation rate was 5% vs 20% in the group with an abnormal duplex (P  .04).
Primary patency was 56% in the normal duplex group and 46% in the abnormal duplex group (P  .18). Early duplex
ultrasound was able to identify a residual stenosis not seen on completion angiography in 56% of cases.
Conclusions: Duplex scanning detects residual stenosis missed with conventional angiography after infrainguinal inter-
ventions. An abnormal DUS in the first 30 days after an intervention is associated with an increased risk of amputation.
This suggests a possible role for intraprocedural DUS, as well as routine postprocedure DUS, close clinical follow-up, and
consideration of reintervention for residual abnormalities in patients treated for CLI. (J Vasc Surg 2011;53:353-8.)
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bIn patients with critical limb ischemia (CLI), infrain-
guinal bypass grafting is an accepted standard for treatment
due to both its durability and revascularization effective-
ness. Endovascular interventions in patients with CLI may
not be as effective as bypass for establishing sufficient limb
perfusion andmay have inferior patency. Norgen et al in the
Trans-Atlantic Intersociety Consensus II classification
(TASC II) guidelines cite average 1-year primary patency of
77% after percutaneous transluminal angioplasty (PTA) for
femoropopliteal stenosis. Five-year patency is 55%. In the
case of PTA for femoropopliteal occlusion, 1-year patency
is 65% and 42% at 5 years.1 Although limb-specific out-
comes may be equivalent, endovascular therapy avoids the
physiologic stress of an operation and recovery is quicker. The
Bypass versus Angioplasty in Severe Ischemia of the Limb
(BASIL) trial demonstrated that with an endovascular first
approach, patients with CLI have similar amputation-free
survival to patients initially treated with bypass grafting.2
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doi:10.1016/j.jvs.2010.08.045Duplex ultrasound surveillance (DUS) of vein bypass
rafts is beneficial for optimizing graft patency.3 Noninva-
ive DUS of infrainguinal vein bypass grafts is a practice
tandard, allowing early identification of stenoses that
ould lead to graft failures, providing an opportunity for
ntervention to preserve graft function and improve long-
erm patency.4 Patency of vein grafts is optimal for those
ith normal DUS findings. Assisted patency of grafts that
re revised based on DUS findings of a flow limiting steno-
is surpass outcomes for grafts without surveillance that fail
nd require subsequent management.5,6 Although associ-
ted with uncertainty both in cost effectiveness and utility,
he role for graft surveillance is still widely accepted. TASC
I guidelines do not recommend routine duplex surveil-
ance after infrainguinal bypass grafting but do support
linical evaluation with the use of ankle-brachial indices
ABI) as a marker for change in graft flow dynamics.
urrently, there is greater uncertainty about the utility and
ole for DUS following endovascular interventions.1,7
Our group has adopted an endovascular first approach,
hen technically feasible, for treatment of patients with
LI. In addition, these interventions are evaluated with
US, even though there are no evidence-based guidelines
o guide decision-making based on DUS findings. As the
ndovascular first approach is increasingly being utilized, it
s relevant to examine roles for DUS after interventions to
etermine if an approach similar to what is routine for vein
ypass grafts is appropriate.
As a starting point, the present study was performed to
valuate whether early duplex ultrasound findings after
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February 2011354 Humphries et alinfrainguinal endovascular interventions for CLI were pre-
dictive of primary patency or the need for major amputa-
tion.
METHODS
A retrospective review of outcomes after peripheral
arterial interventional procedures for CLI was performed.
The study protocol was approved by the University of
California Davis Institutional Review Board.
Demographic data. To identify the cohort, records
were reviewed of all patients who underwent endovascular
procedures performed at the University of California Davis
Medical Center’s multidisciplinary vascular treatment cen-
ter over a 24-month period (from January 2006 to Decem-
ber 2007). Of 591 consecutive procedures, 198 were in-
frainguinal procedures, performed in 156 patients. Four
patients undergoing procedures for acute ischemia were
excluded, leaving 194 interventions in 152 patients to be
reviewed. Of the 152 patients, 39 were excluded for treat-
ment of Rutherford class 1, 2, or 3 disease. Thirty-two
patients did not have a duplex ultrasound within 30 days of
the index procedure. These patients typically were referred
from a distant location, making routine follow-up and
surveillance at UC Davis impractical. Demographic data
were collected on these patients, but they were excluded
from outcomes analysis. Thus, to evaluate the clinical sig-
nificance of early postintervention DUS findings, the out-
comes of 90 limbs in 81 patients treated for CLI who had a
30-day DUS evaluation were examined.
The demographic features, comorbidities, indications
for intervention, Rutherford class, and preprocedure non-
invasive imaging were reviewed. TASC II class was deter-
mined. All arteriograms were reviewed by a board certified
vascular surgeon or interventional cardiologist blinded to
the postprocedure ultrasound findings, need for subse-
quent treatment, and patient outcome. Procedural success
was defined as achieving a residual stenosis less than 30%, in
accordance with uniform reporting standards for assessing
endovascular treatment.8 The primary outcome measure
was amputation rate. Secondary outcomes evaluated were
primary patency, postprocedure complications, the need
for repeat intervention, and death.
Interventions. All interventions were performed by
board certified vascular surgeons or an interventional car-
diologist at the University of California Davis Vascular
Center. The choice of interventional technique was de-
cided on a case-by-case basis. All procedures were per-
formed with fixed imaging under local anesthesia with
conscious sedation. Heparin was routinely administered to
raise the activated clotting time to greater than 250 seconds
prior to intervention. Anticoagulation was maintained
throughout the course of the procedure.
Interventions included balloon angioplasty, cryoplasty,
cutting balloon angioplasty, excisional atherectomy, laser
atherectomy, or stenting. The method of treatment was at
the discretion of the treating physician, recognizing that
cryoplasty and atherectomy are not supported by level one
evidence. Angioplasty balloon inflation times ranged from a0 seconds to 3 minutes. Lesions not able to be crossed
ntraluminally were treated by subintimal angioplasty tech-
iques. Stents were employed in 31 limbs. Placement of
tents varied by operator preference, and no specific criteria
ere in place at the time. Stent type was operator depen-
ent, but the most commonly used were bare nitinol stents.
hese were routinely postdilated. Covered stents were used
n two cases of vascular injury after angioplasty. Although
ntiplatelet therapy was individualized, all patients without
ontraindication were started on aspirin and clopidogrel.
Follow-up. Patients were observed at regular intervals
or at least 24 months (24-32). The initial duplex ultra-
ound study was done within 30 days occurring prior to or
n the day of the first postoperative clinic visit. Doppler
elocity waveforms and ABIs were routinely recorded at the
ime of the first ultrasound surveillance study. In addition
o ankle pressures, toe pressures were routinely measured
ue to the high number of patients with calcified vessels
econdary to diabetes or renal failure with unreliable ABIs.
n patients where arterial calcification obscured ultrasound
maging, velocity ratios were able to be obtained with
ulsed Doppler. All studies were performed in an Inter-
ocietal Commission for Accreditation of Vascular Laboratories-
ccredited vascular laboratory by registered vascular tech-
ologists. A postinterventional abnormality (stenosis or
cclusion) on vascular laboratory assessment with duplex
ltrasound scanning was considered to be a residual abnor-
ality (primary technical failure) when identified within 30
ays of the index procedure.
At each surveillance visit, the entire ipsilateral lower
xtremity arterial system was evaluated with duplex ultra-
ound scanning. Follow-upDUS intervals were flexible and
ailored based on the patients’ symptoms and findings on
he initial study. The general practice was to evaluate pa-
ients at 3- to 6-month intervals during the first year.
emodynamically significant lesions were defined as a peak
ystolic velocity (PSV) 180 cm/s or PSV velocity ratio
2.0. These velocity criteria are based on established crite-
ia for hemodynamically significant abnormalities.4,6 These
elocity criteria have been correlated with an arterial steno-
is 50% (but the present study was not designed to
alidate this correlation, recognizing that duplex criteria
ay be affected by the length of the stenosis or the presence
f proximal disease). Secondary procedures, repeat endo-
ascular therapy, or open surgical revascularization involv-
ng the original treatment site were performed at the dis-
retion of the treating physician. Primary patency was defined
s no evidence of hemodynamically significant stenosis at the
ite of initial treatment. Primary assisted patency was defined
s continued patency after reintervention and secondary pa-
ency as reintervention after occlusion to re-establish patency.
Statistical analysis. Descriptive statistics were utilized
o compare demographic and clinical variables. All demo-
raphic and survival data were evaluated on a per-patient
asis. Amputation-free survival was analyzed by Kaplan-
eier methods. Univariate analysis for risk factors predict-
ng an initial abnormal postprocedural duplex ultrasound
nd amputation-free survival was performed. Multivariate
n
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Volume 53, Number 2 Humphries et al 355analysis using nominal logistic regression modeling was
conducted separately, both for initial abnormal postproce-
dural duplex ultrasound and amputation-free survival. A P
value .05 was considered significant. All data analyses
were conducted using JMP, version 7 (SAS Institute, Cary,
NC). Kaplan-Meier curves were created using SPSS (SPSS
Inc, Chicago Ill).
RESULTS
Demographics. Demographic data collected on 113
patients, including those that did not have a 30-day duplex
ultrasound, ensured no difference in characteristics be-
tween the two groups. The 113 patients studied included
60men (53%) and 53 women (47%). One hundred twenty-
two limbs treated were followed for a minimum of 24
months (range 24-32). Median patient age was 71 years
(range: 43-98). Demographic and clinical data are summa-
rized in Table I. Forty-five patients (40%) were current
smokers, 69 (61%) had diabetes mellitus, and 23 (20%) had
end stage renal disease (ESRD) on dialysis. Only 47 pa-
tients (42%) were on aspirin at the time of initial consulta-
tion, and 18 (16%) were anticoagulated.
Presenting symptoms were ischemic rest pain in 16
(14%) patients. Seventy-two patients (64%) had minor tis-
sue loss, defined as a focal nonhealing ulcer or gangrene
limited to the digit. Twenty-five (22%) had major tissue
loss, defined as diffuse gangrene of the leg or extending
over several digits for which limb salvage was not consid-
ered possible.9 Sixty-three (56%) patients had no prior
infrainguinal vascular procedure. Twenty-five (22%) pa-
Table I. Summarization of demographic data
summarization for all patients undergoing infrainguinal
endovascular interventions
Variables Number %/range
Total patients 113
Gender
Male 60 53
Age (Mean) 71 43-98 y
Race
Caucasian 59 52
African American 25 22
Hispanic 18 16
Asian 11 10
Smokers 76 67
Current 45 40
Previous 31 27
Diabetes mellitus 69 61
ESRD 23 20
Hyperlipidemia 86 76
Hypertension 108 96
Antiplatelet agent 57 50
Aspirin 47 42
Warfarin 18 16
Indications
Rest pain 16 14
Minor tissue loss 72 64
Major tissue loss 25 22tients had previous infrainguinal bypass grafting with ve- mous conduit, and two (2%) had an infrainguinal bypass
rocedure in addition to an aorto-bifemoral bypass. Seven
6%) patients had undergone both bypass grafting and a
revious endovascular procedure. Sixteen (14%) patients
ad undergone previous infrainguinal endovascular inter-
entions.
Thirty-two patients did not have a postprocedure DUS
ithin 30 days of the procedure. There were no demo-
raphic or clinical differences that distinguished patients
hat underwent DUSwithin 30 days and those that did not.
herefore, the 90 patients who had an ultrasound within
0 days of the procedure were subjected to analysis.
Interventions. Balloon angioplasty was the primary
ntervention. Treated lesions were isolated to the SFA and
bove-the-knee popliteal artery in 34% of cases. Isolated
elow-knee popliteal artery and infratibial interventions
ere seen in 39% of cases, and a combination of lesions in
he SFA and infrapopliteal arteries were treated in 18% of
ases. Nine percent of cases involved lesions in a previous
ypass graft. In the cohort with DUS within 30 days, there
ere 108 interventions conducted on 90 patients, 105 of
hich included the use of balloon angioplasty. In the other
hree (3%) cases, excisional atherectomy was the only tech-
ique employed. Atherectomy was used as an adjunct to
alloon angioplasty in 28 procedures (24%). Seven cases
tilized excisional atherectomy while 19 cases used laser
therectomy. The remaining two utilized rotational
therectomy. Cold balloon angioplasty was used in 29
27%) cases. Stents were placed in 31 (34%) limbs. Of these,
our (10%) cases used covered stents. Three patients that
ad a stent placed required amputation vs nine patients that
id not (P .12). Fifteen patients with a stent placed
ccluded the treated segment in the study period, com-
ared with 19 without a stent (P  .11).
Immediate procedural failures. No treated patient
equired acute surgical revascularization and no deaths
ccurred within 30 days of the interventional procedures.
hree patients had immediate procedural failure, defined as
cclusion of the treated segment within 24 hours of the
ndex procedure. All underwent repeat endovascular inter-
ention and limb preservation was achieved. No similar
haracteristics among the three patients or procedures that
ailed were observed. All patients had adequate run-off on
ompletion angiography, and only one of the patients had
n intraprocedural complication of dissection.
Outcomes. Ninety patients underwent duplex ultra-
ound within 30 days of the index procedure. The compar-
son of outcomes between normal vs abnormal postproce-
ure DUS at 2 years is shown in Table II, sorted by limb. In
ome cases more than one site was treated, more than one
ntervention treatment used, or more than one abnormality
ccurred on DUS. Of the 90 limbs with a duplex ultra-
ound at 30 days, 50 limbs had an abnormal ultrasound and
0 limbs had a normal ultrasound. Primary patency was
chieved in 23 (46%) limbs in the group with an abnor-
al 30-day duplex and 26 limbs (56%) with a normal 30-day
uplex. The assisted patency for patients with an abnor-
al duplex was 64% vs 75% in the group with a normal
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February 2011356 Humphries et al30-day duplex scan. Primary patency did not significantly
differ between the groups (P  .18) (Fig 1). Ten (20%)
limbs required major amputation in the abnormal 30-day
ultrasound group, whereas only two (5%) patients with a
normal duplex required major amputation. Kaplan-Meier
analysis comparing patients with a normal DUS at 30 days
to those without showed that patients with a normal DUS
at 30 days were less likely to require major amputation (P
.04) (Fig 2). Amputation-free survival, however, was not
significantly different between these two groups. The 12
amputations included one patient with TASC B disease,
one with TASC C, and 10 patients with TASC D disease.
Two patients in each group went on to have an open
revascularization after their endovascular intervention
failed. Three of the four patients that underwent open
revascularization had TASC D disease; the remaining pa-
tient had TASC C disease. None of the patients that under-
went open revascularization required an amputation.
Univariate analysis showed that renal failure requiring
dialysis was the only demographic factor associated with
increased risk of amputation. Age, sex, other comorbidities,
and the procedure performed were not predictive of ampu-
tation (Table III). Twenty-one (19%) patients in the study
Table II. Two-year, by limb, comparison of patients with
30-day duplex ultrasound after infrainguinal intervention
Lost to
follow-up
(n 6)
Primary patency
n (%)
P  .18
Rei
Normal DUS (n  40) 4 26 (56)
Abnormal DUS (n  50) 2 23 (46)
DUS, Duplex ultrasound scanning.
Fig 1. Kaplan-Meier analysis of primary patency comparing pa-
tients with a normal duplex ultrasound represented by the contin-
uous line with an abnormal 30-day duplex ultrasound represented
by the dashed line.died during the follow-up period. These deaths were evenly sistributed between the normal DUS and abnormal ultra-
ound groups.
In collecting data, the postintervention angiogram was
eviewed for all cases. This allowed for comparison of
ingle-plane completion angiography with velocity findings
n the initial duplex ultrasound. Of the patients with an
bnormal postprocedure ultrasound, 28 had a technically
without a hemodynamically significant stenosis seen on
entions
Assisted
patency
n (%)
Open
revascularization
(n)
Amputation
n (%)
P .04
Death
n (%)
30 (75) 2 2 (5) 8 (20)
32 (64) 2 10 (20) 8 (16)
ig 2. Kaplan-Meier curve representing amputation rates be-
ween patients with abnormal duplex ultrasound surveillance rep-
esented with the dashed line and patients with a normal 30-day
uplex ultrasound represented with a continuous line (P  .04).
able III. Univariate analysis comparing patients with
ormal DUS vs patients with an abnormal initial DUS
Normal Abnormal P value
ypertension 61 17 .50
yslipidemia 43 16 .95
iabetes mellitus 40 8 .14
SRD 7 9 .01
moking 43 14 .55
spirin therapy 34 14 .39
rior intervention 14 2 .12
ngioplasty 61 23 .82
therectomy 17 7 .83
US, Duplex ultrasound scanning; ESRD, end stage renal disease.
nly ESRD was a significant predictor of amputation rate.and
nterv
(n)
4
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Volume 53, Number 2 Humphries et al 357phy) while 22 had 30% residual stenosis (Table IV).
Analysis of this data showed that in 56% of cases, DUS was
able to identify a hemodynamically significant stenosis that
was not recognized on completion angiography by the
reviewing interventionalist.
DISCUSSION
The “endovascular first” approach for CLI due to
infrainguinal arterial occlusive disease is more widely prac-
ticed. Vascular laboratory assessment prior to and after
intervention is a recommended practice standard,10 but the
benefit of vascular laboratory evaluation and surveillance
after these interventions has not been well established.
DUS criteria for reintervention may vary, depending on the
intervention technique and anatomic location of the inter-
vention.
In the present study, similar to experiences reported by
single and multicenter studies,2 endovascular therapy for
CLI was not associated with major short-term complica-
tions. The patient cohort did have significant comorbidi-
ties, however, as the 24-month survival rate was only 82%
and six patients with ESRD required amputation. These
findings support the contention that for many patients with
CLI, even short-term success that results in limb preserva-
tion may have benefit, as periprocedural mortality is low
and CLI patients have limited survival.
Duplex scanning more frequently identified abnormal-
ities (defined as focal doubling of the PSV or a PSV 180
cm/s) than completion arteriography (with a residual ste-
nosis 30% a technically successful procedure) after in-
frainguinal interventions. The ultrasound and arterio-
graphic criteria used represent values for defining technical
success that are commonly accepted and reported through-
out the literature.3,8 These velocity criteria, however, have
not been validated against a known reference standard. The
use of sensitive velocity criteria, as done here, is ideal for
surveillance. These criteria identify treated areas that might
benefit from follow-up and possibly early reintervention to
preserve patency and decrease risk of amputation. In addi-
tion, we have shown that abnormal DUS findings using
these criteria are clearly associated with adverse outcomes,
as 20% of patients with an abnormal postprocedure duplex
required amputation vs 5% with a normal ultrasound. More
stringent criteria, such as PSV 300cm/s or PSV ratio
3.5, may be used to identify critical areas of stenosis at
Table IV. Two-way analysis comparing conventional
angiography and duplex ultrasound
Abnormal 30-day
duplex ultrasound
Normal 30-day
duplex ultrasound
Residual stenosis on
completion angiogram 22 12
No residual stenosis on
completion angiogram 28 28
Angiography missed a lesion seen with duplex ultrasound in 56% of cases.greatest risk for immediate failure that should undergo wepeat intervention. Mills et al have found that in vein
rafts, without reintervention, 70% of these high-grade
esions will go on to occlude.11
Doppler flow velocities and waveform analysis may be
ore sensitive than single plane arteriography in detection
f residual abnormalities following infrainguinal angio-
lasty, atherectomy, or other commonly employed tech-
iques. An intimal flap, small dissections, and fractured
therosclerotic plaque may be difficult to detect arterio-
raphically. In addition, recoil of the treated vessel would
ot be seen on completion angiography.
The observation that finding a DUS abnormality in the
reated arterial segment is associated with a higher risk of
imb loss suggests that postprocedure duplex scanning has
alue in identifying those patients who have a suboptimal
emodynamic result. Duplex was selected as the postpro-
edure technique in this study for its ability to provide
hysiologic information specific to the area of intervention.
ulse volume recordings, ABIs, and oximetry are useful in
he postprocedure evaluation of limb perfusion after treat-
ent. However, for surveillance after intervention these
tudies do not allow one to distinguish between the area
reated and the patient’s other known vascular disease. In
ddition, these methods may not be accurate in patients
ith calcified arteries, such as those with diabetes and renal
ailure.
The apparently high incidence of residual abnormalities
n this study cohort might lead one to question the techni-
al adequacy of the treatments performed, but only 13% of
atients required amputation in this high-risk cohort. This
ompares favorably to other reports of endovascular ther-
py for CLI patients. Giles et al, in their study of infrapop-
iteal angioplasty for patients with CLI (176 limbs), re-
orted a better overall technical success rate (defined as
30% residual stenosis) of 93%.Only arteriographic criteria
ere used to define technical success5 with a 12-month
imb salvage rate that was a comparable 84% overall. The
ASIL trial did not consider residual stenosis to be a
echnical failure nor did the authors report the percentage
f lesions that had residual stenosis after intervention.2
During open surgical revascularization procedures, du-
lex scanning can be used intraoperatively and completion
US assessment of vein bypass grafts is routine practice for
any surgeons. Identifying and correcting technical de-
ects at the time of initial operation helps to produce
ositive outcomes. Johnson et al found a 15% intraopera-
ive revision rate with the use of intraoperative duplex
ltrasound for open vein bypass grafts. In addition, they
ound that only 0.8% of grafts with a normal intraoperative
uplex required revision within 30 days vs 20% of those that
ad an abnormal intraoperative ultrasound.12
Duplex ultrasound has also been used as a technique to
uide endovascular interventions. Ascher et al described over
00 infrainguinal endovascular procedures under duplex ul-
rasound guidance,13 but DUS has not been adopted as a
outine method for completion assessment. Our observation
hat residual abnormalities were more commonly detected
ith DUS than with arteriography suggests that ultrasound
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February 2011358 Humphries et almay be a more sensitive diagnostic tool, or at least a comple-
mentary one. The role of duplex scanning as an intraproce-
dural assessment tool during catheter-based interventions ap-
pears worthy of further study. Intraprocedural DUS might
provide additional objective information about the adequacy
of interventions and it might identify the need for additional
maneuvers, such as repeat balloon dilatation, additional
atherectomy, or placement of a stent.
The natural history of a vein graft stenosis is disease
progression and potential occlusion resulting in limb loss.
Repair of DUS-diagnosed vein graft stenosis prior to occlu-
sion improves amputation-free survival.11 Similarly, it ap-
pears that endovascular interventions with a residual or
recurrent stenosis are likely to progress to failure if not
treated.4 Using DUS to monitor endovascular interven-
tions allows surgeons the ability to identify those patients
with disadvantaged arterial segments that are at risk for
arterial occlusion—those most likely to need additional
interventions to ensure limb salvage.
Other investigators have shown that TASC D disease is
associated with decreased limb salvage when treated by endo-
vascular means.5 We did not specifically look at TASC classi-
fication as a risk for failure of the interventionor progressionof
disease. However, post hoc analysis showed that TASC D
lesions were present in nine of 12 (75%) patients that failed
endovascular treatment and required amputation. Three of
the nine patients had previous bypass grafts that were chroni-
cally occluded. None of these patients were candidates for
openbypass grafting due to poor distal targets, patient comor-
bidities, or lack of sufficient conduit.
There are several limitations to this retrospective study.
It is not randomized, which potentially introduces bias.
Outcomes are observed and reported, but causality cannot
be established. In addition, patients that did not have a
duplex at 30 days, for whatever reason, were excluded from
the analysis, and repeat studies after 30 days were not
consistently obtained. However, recognizing the limita-
tions of this study has allowed us to design new protocols
for evaluating patients after endovascular interventions. It
has also prompted selected use of intraprocedural ultra-
sound to evaluate treated segments. Future studies may
determine if this will improve outcomes.
In conclusion, patients with CLI compose a group with
high risk for mortality and complex anatomy for endovas-
cular intervention. Early postprocedure duplex scanning
can identify residual defects not seen by conventional an-
giography. For patients with CLI, an abnormal postproce-
dure DUS correlates with an increased rate of limb loss.
Although not studied, reintervention for residual defects
found on DUS may improve limb salvage. Intraprocedural
duplex scanning may also improve clinical outcome,
though this has yet to be established.
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